Security key
055477103
Bicara Therapeutics Inc. - Common Stock, par value $0.0001 per share (BCAX)
CUSIP: 055477103
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 36,408,664
- Total 13F value
- $927,393,381
- Share change
- +33,335,115
- SEC-reported price per share
- $25.47
- Number of holders
- 69
- Value change
- +$849,110,088
- Number of buys
- 67
- Shares outstanding
- 65,361,446
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
69
Top holders
10
BCAX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2024
Bicara Therapeutics Inc. SEC filings
Bicara Therapeutics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 055477103
Recent filing periods:
Ownership snapshot
Top reported holders of BCAX - Bicara Therapeutics Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Biocon Ltd
Disclosed value leader
Biocon Ltd
Comparable rows
0/5
Latest evidence
17 Sep 2024
3/4/5
Highest disclosed value: $73,155,178
5 rows are not safely comparable across share classes.
Quick read
Biocon Ltd has the largest disclosed position value at $73.16M.
0 of 5 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Biocon Ltd's linked filing trail.
Disclosed position value
Top 5
Biocon Ltd
$73.16M
TPG GP A, LLC
$25.96M
James E. Flynn
$23.77M
FMR LLC
$14.77M
FIL Ltd
$13.43M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-5 of 5 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Biocon Ltd |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$73,155,178
5,523,897 shares
|
— | 16 Sep 2024 |
| TPG GP A, LLC |
3/4/5
Former 10% Owner
|
—
class O/S missing
|
$25,962,692
1,960,425 shares
|
— | 16 Sep 2024 |
| James E. Flynn |
3/4/5
Possible Members of 10% Group, 10%+ Owner
|
—
class O/S missing
|
$23,774,208
1,795,174 shares
|
— | 17 Sep 2024 |
| FMR LLC |
3/4/5
Other*
|
—
class O/S missing
|
$14,770,801
1,115,333 shares
|
— | 16 Sep 2024 |
| FIL Ltd |
3/4/5
Other*
|
—
class O/S missing
|
$13,426,861
1,013,853 shares
|
— | 16 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
69
Shares
36,408,664
Rows available
69
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q1 2026 Across Filers
Q1 2026 holders
144
Q3 2024 holders
69
Holder diff
-75
| Investor | Q1 2026 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q1 2026 value | Q3 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend